OBJECTIVE: To determin the extent to which parvovirus B19 (B19V) and co-infection of B19V and malaria contribute to risk of anaemia in children. METHODS: B19V DNA and malaria parasites were screened for 234 children at the PML Children's Hospital in Accra. The role of B19V and co-infection with B19V and malaria in anaemia was evaluated by analysing full blood cell counts, malaria and B19V DNA results from these children. RESULTS: The prevalence of B19V, malaria and co-infection with B19V and malaria was 4.7%, 41.9% and 2.6%, respectively. Malaria posed a greater risk in the development of mild anaemia compared to severe anaemia (OR=5.28 vrs 3.15) whereas B19V posed a higher risk in the development of severe anaemia compared to mild anaemia (OR=4.07 vrs 1.00) from a non-anaemic child. Persons with co-infection with B19V and malaria had 2.23 times the risk (95% CI=0.40-12.54) of developing severe anaemia should they already have a mild anaemia. The degree of anaemia was about three times affected by co-infection (Pillai's trace=0.551, P=0.001) as was affected by malaria alone (Pillai's trace=0.185, P=0.001). B19V alone did not significantly affect the development of anaemia in a non-anaemic child. Microcytic anaemia was associated with B19V and co-infection with B19V and malaria more than normocytic normochromic anaemia. CONCLUSIONS: B19V was associated with malaria in cases of severe anaemia. The association posed a significant risk for exacerbation of anaemia in mild anaemic children. B19V and co-infection with B19V and malaria may be associated with microcytic anaemia rather than normocytic normochromic anaemia as seen in cases of B19V infection among persons with red cell abnormalities.
OBJECTIVE: To determin the extent to which parvovirus B19 (B19V) and co-infection of B19V and malaria contribute to risk of anaemia in children. METHODS: B19V DNA and malaria parasites were screened for 234 children at the PMLChildren's Hospital in Accra. The role of B19V and co-infection with B19V and malaria in anaemia was evaluated by analysing full blood cell counts, malaria and B19V DNA results from these children. RESULTS: The prevalence of B19V, malaria and co-infection with B19V and malaria was 4.7%, 41.9% and 2.6%, respectively. Malaria posed a greater risk in the development of mild anaemia compared to severe anaemia (OR=5.28 vrs 3.15) whereas B19V posed a higher risk in the development of severe anaemia compared to mild anaemia (OR=4.07 vrs 1.00) from a non-anaemic child. Persons with co-infection with B19V and malaria had 2.23 times the risk (95% CI=0.40-12.54) of developing severe anaemia should they already have a mild anaemia. The degree of anaemia was about three times affected by co-infection (Pillai's trace=0.551, P=0.001) as was affected by malaria alone (Pillai's trace=0.185, P=0.001). B19V alone did not significantly affect the development of anaemia in a non-anaemic child. Microcytic anaemia was associated with B19V and co-infection with B19V and malaria more than normocytic normochromic anaemia. CONCLUSIONS: B19V was associated with malaria in cases of severe anaemia. The association posed a significant risk for exacerbation of anaemia in mild anaemic children. B19V and co-infection with B19V and malaria may be associated with microcytic anaemia rather than normocytic normochromic anaemia as seen in cases of B19V infection among persons with red cell abnormalities.
Entities:
Keywords:
Anaemia; Children; Ghana; Human parvovirus B19; Malaria
Authors: C G Potter; A C Potter; C S Hatton; H M Chapel; M J Anderson; J R Pattison; D A Tyrrell; P G Higgins; J S Willman; H F Parry Journal: J Clin Invest Date: 1987-05 Impact factor: 14.808
Authors: Elizabeth T Rogawski; Ebbie Chaluluka; Malcolm E Molyneux; Gaoqian Feng; Stephen J Rogerson; Steven R Meshnick Journal: Clin Infect Dis Date: 2012-07-05 Impact factor: 9.079
Authors: David K Lewis; Christopher J M Whitty; Amanda L Walsh; Henry Epino; Nynke R van den Broek; Elizabeth A Letsky; Clyton Munthali; Joshua M Mukiibi; Martin J Boeree Journal: Trans R Soc Trop Med Hyg Date: 2005-08 Impact factor: 2.184
Authors: Simon Brooker; Willis Akhwale; Rachel Pullan; Benson Estambale; Siân E Clarke; Robert W Snow; Peter J Hotez Journal: Am J Trop Med Hyg Date: 2007-12 Impact factor: 2.345
Authors: D Schellenberg; J R M Armstrong Schellenberg; A Mushi; D de Savigny; L Mgalula; C Mbuya; C G Victora Journal: Bull World Health Organ Date: 2003-10-14 Impact factor: 9.408
Authors: K R Muir; C E D Chilvers; C Harriss; L Coulson; M Grainge; P Darbyshire; C Geary; J Hows; J Marsh; T Rutherford; M Taylor; E C Gordon-Smith Journal: Br J Haematol Date: 2003-12 Impact factor: 6.998
Authors: Tony Bokalanga Wawina; Olivier Mbaya Tshiani; Steve Mundeke Ahuka; Elisabeth Simbu Pukuta; Michel Ntetani Aloni; Christopher Jacob Kasanga; Jean-Jacques Tamfum Muyembe Journal: Int J Infect Dis Date: 2017-09-22 Impact factor: 3.623
Authors: Akshaya Ramesh; Sara Nakielny; Jennifer Hsu; Mary Kyohere; Oswald Byaruhanga; Charles de Bourcy; Rebecca Egger; Boris Dimitrov; Yun-Fang Juan; Jonathan Sheu; James Wang; Katrina Kalantar; Charles Langelier; Theodore Ruel; Arthur Mpimbaza; Michael R Wilson; Philip J Rosenthal; Joseph L DeRisi Journal: PLoS One Date: 2019-06-20 Impact factor: 3.240
Authors: Nguyen L Toan; Bui T Sy; Le H Song; Hoang V Luong; Nguyen T Binh; Vu Q Binh; Reinhard Kandolf; Thirumalaisamy P Velavan; Peter G Kremsner; C-Thomas Bock Journal: BMC Infect Dis Date: 2013-08-15 Impact factor: 3.090